PharmaTher Enters Into Process Development Agreement With LTS LOHMANN for Ketamine Microneedle Patch Dec 20, 2021
Revive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for Development of Psilocybin… Nov 3, 2021
PharmaTher Provides Product Pipeline Updates and Anticipated Milestones for Q4-2021 and 2022 Sep 13, 2021
PharmaTher Files FDA Pre-IND Meeting Request and Briefing Package For KETABET™ To Treat Depression Jun 15, 2021